Brambilla P, Lissau I, Flodmark C-E, Moreno L A, Widhalm K, Wabitsch M, Pietrobelli A
ASL Provincia di Milano 2, Milano, Italy.
Int J Obes (Lond). 2007 Apr;31(4):591-600. doi: 10.1038/sj.ijo.0803581.
The diagnostic criteria of the metabolic syndrome (MS) have been applied in studies of obese adults to estimate the metabolic risk-associated with obesity, even though no general consensus exists concerning its definition and clinical value. We reviewed the current literature on the MS, focusing on those studies that used the MS diagnostic criteria to analyze children, and we observed extreme heterogeneity for the sets of variables and cutoff values chosen.
To discuss concerns regarding the use of the existing definition of the MS (as defined in adults) in children and adolescents, analyzing the scientific evidence needed to detect a clustering of cardiovascular risk-factors. Finally, we propose a new methodological approach for estimating metabolic risk-factor clustering in children and adolescents.
Major concerns were the lack of information on the background derived from a child's family and personal history; the lack of consensus on insulin levels, lipid parameters, markers of inflammation or steato-hepatitis; the lack of an additive relevant effect of the MS definition to obesity per se. We propose the adoption of 10 evidence-based items from which to quantify metabolic risk-factor clustering, collected in a multilevel Metabolic Individual Risk-factor And CLustering Estimation (MIRACLE) approach, and thus avoiding the use of the current MS term in children.
Pediatricians should consider a novel and specific approach to assessing children/adolescents and should not simply derive or adapt definitions from adults. Evaluation of insulin and lipid levels should be included only when specific references for the relation of age, gender, pubertal status and ethnic origin to health risk become available. This new approach could be useful for improving the overall quality of patient evaluation and for optimizing the use of the limited resources available facing to the obesity epidemic.
代谢综合征(MS)的诊断标准已应用于肥胖成年人的研究中,以评估与肥胖相关的代谢风险,尽管对于其定义和临床价值尚无普遍共识。我们回顾了关于MS的当前文献,重点关注那些使用MS诊断标准分析儿童的研究,我们观察到所选变量集和临界值存在极大的异质性。
讨论在儿童和青少年中使用现有MS定义(如在成年人中所定义的)的相关问题,分析检测心血管危险因素聚集所需的科学证据。最后,我们提出一种新的方法来评估儿童和青少年的代谢危险因素聚集情况。
主要问题包括缺乏来自儿童家庭和个人病史的背景信息;在胰岛素水平、脂质参数、炎症或脂肪性肝炎标志物方面缺乏共识;MS定义对肥胖本身缺乏附加的相关影响。我们建议采用10项基于证据的指标来量化代谢危险因素聚集情况,通过多级代谢个体危险因素和聚集评估(MIRACLE)方法收集,从而避免在儿童中使用当前的MS术语。
儿科医生应考虑采用一种新颖且特定的方法来评估儿童/青少年,而不应简单地从成年人那里推导或改编定义。仅当有关于年龄、性别、青春期状态和种族起源与健康风险关系的具体参考资料时,才应纳入胰岛素和脂质水平的评估。这种新方法可能有助于提高患者评估的整体质量,并优化面对肥胖流行时有限资源的利用。